$VINE
Fresh Vine Wine, Inc. Stock $vine

$vine Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024021045 Filed on March 08, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$104.6K	$239.5K	$1.826M
YoY Change	-74.41%	-36.29%	-36.15%
Cost Of Revenue	$215.8K	$780.6K	$4.412M
YoY Change	-47.62%	55.7%	72.96%
Gross Profit	-$111.2K	-$541.2K	-$2.586M
YoY Change	3208.98%	331.4%	-936.89%
Gross Profit Margin	-106.39%	-225.97%	-141.6%
Selling, General & Admin	$1.099M	$1.511M	$6.322M
YoY Change	-34.27%	-58.96%	-44.98%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$0.00	$0.00
YoY Change			-100.0%
% of Gross Profit
Operating Expenses	$1.099M	$1.511M	$6.322M
YoY Change	-34.27%	-58.96%	-44.98%
Operating Profit	-$1.212M	-$2.052M	-$10.62M
YoY Change	-39.75%	-46.09%	-30.31%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$39.00	$0.00	$500.0K
YoY Change	-96.82%	-100.0%	400.47%
Pretax Income	-$1.212M	-$2.052M	-$10.62M
YoY Change	-39.71%	-45.96%	-30.18%
Income Tax
% Of Pretax Income
Net Earnings	-$1.212M	-$2.094M	-$10.62M
YoY Change	-39.71%	-44.85%	-30.18%
Net Earnings / Revenue	-1159.36%	-874.44%	-581.27%
Basic Earnings Per Share	-$0.08		-$0.69
Diluted Earnings Per Share	-$0.08	-$0.13	-$0.69
COMMON SHARES
Basic Shares Outstanding	15.98M shares	15.98M shares	15.33M shares
Diluted Shares Outstanding	15.98M shares		15.33M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$58.81K	$236.3K	$236.3K
YoY Change	-97.74%	-88.64%	-88.64%
Cash & Equivalents	$59.00K	$236.0K
Short-Term Investments
Other Short-Term Assets	$104.8K	$142.9K	$142.9K
YoY Change	-89.9%	-86.12%	-86.12%
Inventory	$172.3K	$337.9K	$337.9K
Prepaid Expenses	$3.871K	$9.871K
Receivables	$48.98K	$172.1K	$172.1K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$384.9K	$889.3K	$889.3K
YoY Change	-94.77%	-88.75%	-88.75%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$500.0K	$500.0K	$500.0K
YoY Change
Other Assets		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Assets	$500.0K	$500.0K	$500.0K
YoY Change	-16.66%	-26.27%	-26.27%
TOTAL ASSETS
Total Short-Term Assets	$384.9K	$889.3K	$889.3K
Total Long-Term Assets	$500.0K	$500.0K	$500.0K
Total Assets	$884.9K	$1.389M	$1.389M
YoY Change	-88.89%	-83.82%	-83.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.101M	$509.3K	$1.095M
YoY Change	41.62%	-13.56%	-40.45%
Accrued Expenses	$847.6K	$810.7K	$1.120M
YoY Change	61.03%	91.69%	-0.29%
Deferred Revenue		$3.407K
YoY Change
Short-Term Debt	$15.00K	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.865M	$2.219M	$2.219M
YoY Change	84.27%	-25.36%	-25.36%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.865M	$2.219M	$2.219M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$2.865M	$2.219M	$2.219M
YoY Change	84.27%	-25.36%	-25.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.70M	-$26.50M
YoY Change	55.35%	67.51%
Common Stock	$15.98K	$15.98K
YoY Change	0.63%	25.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.980M	-$829.5K	-$829.5K
YoY Change
Total Liabilities & Shareholders Equity	$884.9K	$1.389M	$1.389M
YoY Change	-88.89%	-83.82%	-83.82%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.212M	-$2.094M	-$10.62M
YoY Change	-39.71%	-44.85%	-30.18%
Depreciation, Depletion And Amortization		$0.00	$0.00
YoY Change			-100.0%
Cash From Operating Activities	-$332.8K	-$223.6K	-$4.800M
YoY Change	-84.09%	-82.35%	-64.52%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions			$400.0K
YoY Change
Other Investing Activities		-$500.0K	-$500.0K
YoY Change
Cash From Investing Activities		-$500.0K	-$500.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$105.3K	200.0K	$3.565M
YoY Change	-95.97%	-392.87%	-882.91%
NET CHANGE
Cash From Operating Activities	-$332.8K	-223.6K	-$4.800M
Cash From Investing Activities		-500.0K	-$500.0K
Cash From Financing Activities	$105.3K	200.0K	$3.565M
Net Change In Cash	-$227.5K	-523.6K	-$1.735M
YoY Change	-143.48%	-60.78%	-87.59%
FREE CASH FLOW
Cash From Operating Activities	-$332.8K	-$223.6K	-$4.800M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Auditor Firm AuditorFirmId	344
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41147
CY2023	dei	Entity Registrant Name EntityRegistrantName	FRESH VINE WINE, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3905007
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1250000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	810723	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	422931	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3407	usd
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	P.O. Box 78984
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Charlotte
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28271
CY2023	dei	City Area Code CityAreaCode	(855)
CY2023	dei	Local Phone Number LocalPhoneNumber	766-9463
CY2023	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value
CY2023	dei	Trading Symbol TradingSymbol	VINE
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	3207021	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15976227	shares
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	Wipfli LLP
CY2023	dei	Auditor Location AuditorLocation	Minneapolis, Minnesota
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	236340	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2080335	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	172101	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	259317	usd
CY2023Q4	us-gaap	Net Investment In Lease NetInvestmentInLease	0	usd
CY2022Q4	us-gaap	Net Investment In Lease NetInvestmentInLease	20000	usd
CY2022Q4	vine	Due From Employees Current01 DueFromEmployeesCurrent01	37733	usd
CY2022Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	804907	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	337873	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3696198	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	42943	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	961211	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	68286	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	889257	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7907987	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	500000	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	678167	usd
CY2023Q4	us-gaap	Assets Assets	1389257	usd
CY2022Q4	us-gaap	Assets Assets	8586154	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	509337	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	589204	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	420413	usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	585976	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2218776	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2972548	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2218776	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2972548	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	10	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15976227	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15976227	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12732257	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12732257	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	15976	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12732	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25631255	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21420732	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26476760	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15819858	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-829519	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5613606	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1389257	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8586154	usd
CY2023	us-gaap	Revenues Revenues	1826190	usd
CY2022	us-gaap	Revenues Revenues	2860001	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	4412119	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2551009	usd
CY2023	us-gaap	Gross Profit GrossProfit	-2585929	usd
CY2022	us-gaap	Gross Profit GrossProfit	308992	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6322184	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11489804	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1708218	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	4053123	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-10616331	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-15233936	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1296	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	31429	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-10615035	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15202507	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	41867	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10656902	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15202507	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15329617	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12550096	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15329617	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12550096	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	17075990	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2506823	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1233300	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15202507	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5613606	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2546728	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	950000	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	41867	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	717049	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-10615035	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-829519	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-10615035	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15202507	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3990	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1708218	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4053123	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	1844210	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	37733	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-87216	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	51157	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-153075	usd
CY2023	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	-804907	usd
CY2022	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	804907	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-146314	usd
CY2022	us-gaap	Increase Decrease In Notes Receivable Related Parties Current IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent	-376000	usd
CY2022	us-gaap	Increase Decrease In Due From Employee Current IncreaseDecreaseInDueFromEmployeeCurrent	37733	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1514115	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3537138	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-605268	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-189776	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-79867	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	172488	usd
CY2023	vine	Increase Decrease In Accrued Compensation IncreaseDecreaseInAccruedCompensation	-420413	usd
CY2022	vine	Increase Decrease In Accrued Compensation IncreaseDecreaseInAccruedCompensation	3999	usd
CY2023	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	-664024	usd
CY2022	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	1250000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	345923	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	210065	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	29333	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-249617	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-6593	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-3750	usd
CY2022	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	-200272	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4809009	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13528251	usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-500000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	216000	usd
CY2022	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-171069	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	950000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	68286	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	2615014	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3565014	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-455355	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1743995	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-13983606	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2080335	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16063941	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	336340	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2080335	usd
CY2023	vine	Dividends Declared But Not Paid DividendsDeclaredButNotPaid	41867	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4800000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13500000	usd
CY2023Q4	vine	Working Capital WorkingCapital	1300000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	236000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	100000	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1000000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration:underline">Accounting Estimates</span></i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management uses estimates and assumptions in preparing these financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include allowance for doubtful accounts, allowance for inventory obsolescence, equity-based compensation for employees and non-employees, and the valuation of deferred tax assets.</p>
CY2023Q4	us-gaap	Cash Cash	100000	usd
CY2023Q4	us-gaap	Inventory Net Of Allowances Customer Advances And Progress Billings InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings	112000	usd
CY2022Q4	us-gaap	Inventory Net Of Allowances Customer Advances And Progress Billings InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings	0	usd
CY2023Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	3407	usd
CY2022Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	10000	usd
CY2022Q1	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	13750	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	10000	usd
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	13750	usd
CY2023Q4	us-gaap	Receivables From Customers ReceivablesFromCustomers	172101	usd
CY2022Q4	us-gaap	Receivables From Customers ReceivablesFromCustomers	259317	usd
CY2022Q1	us-gaap	Receivables From Customers ReceivablesFromCustomers	208160	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.50	pure
CY2023	vine	Unrecognized Equitybased Compensation Expense UnrecognizedEquitybasedCompensationExpense	0	usd
CY2022	vine	Unrecognized Equitybased Compensation Expense UnrecognizedEquitybasedCompensationExpense	991167	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	1576325	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	3059429	usd
CY2023Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	4000000	usd
CY2023	us-gaap	Stockholders Equity Other StockholdersEquityOther	712000	usd
CY2023Q4	us-gaap	Stockholders Equity Other StockholdersEquityOther	2000000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-10615035	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15202507	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	41867	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10656902	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15202507	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15329617	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12550096	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15329617	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12550096	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
CY2023Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	50000	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14748862	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2721562	shares
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	1800000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	112000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	337873	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3683159	usd
CY2022Q4	us-gaap	Retail Related Inventory Merchandise RetailRelatedInventoryMerchandise	13039	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	337873	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3696198	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9871	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	313000	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	678167	usd
CY2022Q4	us-gaap	Deposits Assets DepositsAssets	569377	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	33072	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	78834	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	42943	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1639378	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	500000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	420413	usd
CY2023Q4	vine	Sponsorship Agreements Current SponsorshipAgreementsCurrent	608818	usd
CY2022Q4	vine	Sponsorship Agreements Current SponsorshipAgreementsCurrent	234494	usd
CY2023Q4	vine	Accrued Credit Card Charges Current AccruedCreditCardChargesCurrent	7275	usd
CY2022Q4	vine	Accrued Credit Card Charges Current AccruedCreditCardChargesCurrent	21013	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	41867	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	125704	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	89200	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	27059	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	78224	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	810723	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	422931	usd
	us-gaap	Marketing Expense MarketingExpense	141000	usd
CY2023Q1	us-gaap	Temporary Equity Shares Subscribed But Unissued TemporaryEquitySharesSubscribedButUnissued	6366129	shares
CY2023Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.25
CY2023Q1	us-gaap	Financial Instrument Subject To Mandatory Redemption Par Value Per Share FinancialInstrumentSubjectToMandatoryRedemptionParValuePerShare	0.5
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1
CY2023Q1	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	3140000	usd
CY2023	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	2600000	usd
CY2023	us-gaap	Sale Leaseback Transaction Gross Proceeds Investing Activities SaleLeasebackTransactionGrossProceedsInvestingActivities	3930000	usd
CY2023Q4	vine	Aggregate Share Purchase AggregateSharePurchase	10000	shares
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	400000	usd
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.05
CY2023	vine	Common Stock Outstanding Percentage CommonStockOutstandingPercentage	0.199	pure
CY2023	vine	Capital Or Surplus Of Percentage CapitalOrSurplusOfPercentage	1.50	pure
CY2023	vine	Stock Issued And Outstanding StockIssuedAndOutstanding	0.50	pure
CY2023	vine	Per Share Percentage PerSharePercentage	2	pure
CY2023	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.12	pure
CY2023	us-gaap	Investment Company Purchase Premium Per Share InvestmentCompanyPurchasePremiumPerShare	0.47
CY2023	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	41867	usd
CY2022	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	970000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1030000	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1233300	usd
CY2023	vine	Unrecognized Equitybased Compensation Expense UnrecognizedEquitybasedCompensationExpense	0	usd
CY2022	vine	Unrecognized Equitybased Compensation Expense UnrecognizedEquitybasedCompensationExpense	991167	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	991167	shares
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1658485	usd
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	47800	shares
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	219648	usd
CY2022Q4	us-gaap	Employee Stock Ownership Plan Esop Number Of Suspense Shares EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares	10000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	6666	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	6666	shares
CY2022Q2	vine	Unvested Shares Of Restricted Stock unvestedSharesOfRestrictedStock	66666	shares
CY2023	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.25	pure
CY2023	vine	Options Installments Percentage OptionsInstallmentsPercentage	0.20	pure
CY2023	vine	Options Remained Shares optionsRemainedShares	375000	shares
CY2021Q4	vine	Warrants Purchase Shares WarrantsPurchaseShares	110000	shares
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	12
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P1Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P4Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.75	pure
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	407000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	8000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6234000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3874000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	23900000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2229000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3193000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-377000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.036	pure
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-162000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.011	pure
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2360000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.222	pure
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3355000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.221	pure
CY2023	vine	Effective Income Tax Reconciliation Stock Award Forfeiture EffectiveIncomeTaxReconciliationStockAwardForfeiture	440000	usd
CY2023	vine	Effective Income Tax Rate Reconcilation Stock Award Forfeiture EffectiveIncomeTaxRateReconcilationStockAwardForfeiture	-0.043	pure
CY2022	vine	Effective Income Tax Rate Reconcilation Stock Award Forfeiture EffectiveIncomeTaxRateReconcilationStockAwardForfeiture	0	pure
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-102000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0	pure
CY2023	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-92000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.009	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0	pure
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	3000	usd
CY2023Q4	vine	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	1000	usd
CY2022Q4	vine	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	1000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	120000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	868000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5686000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3002000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	27000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	9100000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	13300000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	2200000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.50	pure
CY2023Q4	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	162553	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	99906	usd
CY2022Q2	us-gaap	Management Fee Expense ManagementFeeExpense	50000	usd
CY2022	vine	Service Revenue Related To Agreement ServiceRevenueRelatedToAgreement	297224	usd
CY2022	vine	Purchase Of Inventory PurchaseOfInventory	195116	usd
CY2022Q1	vine	Expense Related To Agreement ExpenseRelatedToAgreement	275000	usd
CY2022Q2	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	5000	usd
CY2023	vine	Base Compensation And Commission Expense BaseCompensationAndCommissionExpense	40000	usd
CY2022	vine	Base Compensation And Commission Expense BaseCompensationAndCommissionExpense	90000	usd
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1250000	usd
CY2023	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	805000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	400000	usd
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	250000	shares
CY2023Q4	us-gaap	Shares Issued SharesIssued	500000	shares
CY2023	vine	Termination Fee TerminationFee	1000000	usd
CY2023	us-gaap	Other Expenses OtherExpenses	500000	usd
CY2023	vine	Shareholders Merger Agreement Percentage ShareholdersMergerAgreementPercentage	0.10	pure
CY2023	vine	Outstanding Shares Percentage OutstandingSharesPercentage	0.42	pure
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2023Q4	vine	Due From Employees Current01 DueFromEmployeesCurrent01		usd
CY2023Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent		usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments		usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization		usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
CY2023	us-gaap	Increase Decrease In Notes Receivable Related Parties Current IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent		usd
CY2023	us-gaap	Increase Decrease In Due From Employee Current IncreaseDecreaseInDueFromEmployeeCurrent		usd
CY2023	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties		usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt		usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	vine	Dividends Declared But Not Paid DividendsDeclaredButNotPaid		usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2023Q4	us-gaap	Retail Related Inventory Merchandise RetailRelatedInventoryMerchandise		usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	vine	Effective Income Tax Reconciliation Stock Award Forfeiture EffectiveIncomeTaxReconciliationStockAwardForfeiture		usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		usd
CY2022	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory		usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001880343

Files In Submission

Name	View Source	Status
0001213900-24-021045-index-headers.html	Edgar Link	pending
0001213900-24-021045-index.html	Edgar Link	pending
0001213900-24-021045.txt	Edgar Link	pending
0001213900-24-021045-xbrl.zip	Edgar Link	pending
ea0201029-10k_freshvine.htm	Edgar Link	pending
ea0201029ex-231_freshvine.htm	Edgar Link	pending
ea0201029ex19-1_freshvine.htm	Edgar Link	pending
ea0201029ex3-5_freshvine.htm	Edgar Link	pending
ea0201029ex31-1_freshvine.htm	Edgar Link	pending
ea0201029ex31-2_freshvine.htm	Edgar Link	pending
ea0201029ex32-1_freshvine.htm	Edgar Link	pending
ea0201029ex97-1_freshvine.htm	Edgar Link	pending
ex19-1_001.jpg	Edgar Link	pending
ex97-1_001.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0201029-10k_freshvine_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vine-20231231.xsd	Edgar Link	pending
vine-20231231_def.xml	Edgar Link	unprocessable
vine-20231231_pre.xml	Edgar Link	unprocessable
vine-20231231_cal.xml	Edgar Link	unprocessable
vine-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VINE
Fresh Vine Wine, Inc. Stock $vine

2024 Q1 Form 10-K Financial Statement

#000121390024021045 Filed on March 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VINE Fresh Vine Wine, Inc. Stock $vine

2024 Q1 Form 10-K Financial Statement

#000121390024021045 Filed on March 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VINE
Fresh Vine Wine, Inc. Stock $vine